Yoav Mazor
Overview
Explore the profile of Yoav Mazor including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
329
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang L, Mazor Y, Prott G, Jones M, Malcolm A
Neurogastroenterol Motil
. 2025 Mar;
:e70006.
PMID: 40032992
Background: Anal slow waves (SW) and ultraslow waves (USW) have been documented previously, yet their significance remains uncertain. Our aims were to characterize the prevalence and features of SW and...
2.
Mazor Y, Leach M, Jones M, Ejova A, Fisher C, Joffe D, et al.
Neurogastroenterol Motil
. 2024 Dec;
37(2):e14975.
PMID: 39627962
Background: Autonomic dysfunction may contribute to symptom generation in irritable bowel syndrome (IBS), possibly driven by psychological morbidity and activation of the hypothalamic-pituitary-adrenal axis. Previous data are conflicting, perhaps due...
3.
Trieu R, Mazor Y, Verdon C, Jones M, Ejova A, Burton G, et al.
Am J Gastroenterol
. 2024 Sep;
PMID: 39248599
Introduction: Obstetric anal sphincter injury (OASI) is associated with serious morbidity and reduced quality of life. The role of anorectal manometry (ARM) to guide treatment is unclear. We aimed to...
4.
Mazor Y, Engelmayer N, Nashashibi H, Rottenfusser L, Lev S, Binshtok A
Inflamm Bowel Dis
. 2024 Mar;
30(10):1843-1851.
PMID: 38478397
Background: Transient receptor potential vanilloid 1 (TRPV1) cation channels, expressed on nociceptors, are well established as key contributors to abdominal pain in inflammatory bowel disease (IBD). Previous attempts at blocking...
5.
Li S, Mazor Y, Park C, Jones M, Malcolm A
United European Gastroenterol J
. 2024 Feb;
12(4):496-503.
PMID: 38412024
Background: Faecal incontinence is a common debilitating condition associated with poor quality of life that generates substantial economic strain on healthcare systems. Objectives: We aimed to evaluate, in a tertiary...
6.
Mazor Y, Malcolm A
Aliment Pharmacol Ther
. 2024 Jan;
59(4):573-574.
PMID: 38247146
No abstract available.
7.
Mazor Y, Schnitzler M, Jones M, Ejova A, Malcolm A
Neurogastroenterol Motil
. 2023 Apr;
35(8):e14592.
PMID: 37036403
Background: Patients with obstructed defecatory symptoms (ODS) are commonly referred to either gastroenterologists (GE) or colorectal surgeons (CS). Further management of these patients may be impacted by this choice of...
8.
Trieu R, Prott G, Sequeira C, Jones M, Mazor Y, Schnitzler M, et al.
Neurogastroenterol Motil
. 2023 Mar;
35(7):e14580.
PMID: 36989181
Introduction: The use of a footstool has been advocated to optimize posture when sitting on the toilet and thus facilitate bowel evacuation. We aimed to assess the alterations in defecatory...
9.
Caspi Y, Mazar M, Kushnir Y, Mazor Y, Katz B, Lev S, et al.
Pain
. 2023 Jan;
164(6):1388-1401.
PMID: 36645177
Physiological or pathology-mediated changes in neuronal activity trigger structural plasticity of the action potential generation site-the axon initial segment (AIS). These changes affect intrinsic neuronal excitability, thus tuning neuronal and...
10.
Kaplan A, Mazor Y, Prott G, Sequeira C, Jones M, Malcolm A
Neurogastroenterol Motil
. 2022 Dec;
35(4):e14524.
PMID: 36578247
Background: Recent community-based studies have demonstrated that experiencing multiple concurrent functional gastrointestinal disorders (FGIDs) is associated with increased somatization, worse quality of life (QoL), and greater health care utilization. However,...